Riskpilot← Back to searchSign inGet full accessÖsterängen C apotek AB
ABBankruptOrg 5593123747Retail sale of pharmaceutical products · NACE 4773Est. 20210 employees
Revenue 2021
SEK 165K
EBITDA margin
-71.5%
Equity ratio
19.1%
Financial strength
Net profit 2021
SEK -142K
0 employees
| Revenue | SEK 165K | — |
| EBITDA | SEK -118K | — |
| Net profit | SEK -142K | — |
| Total assets | SEK 3,2M | — |
| Equity | SEK 608K | — |
| Employees | 0 | — |
Legal name
Österängen C apotek AB
Org number
5593123747
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
15 april 2021
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva handel med receptbelagda apotekvaror, receptfria apoteksvaror och handelsvaror som lämpar sig för försäljning och distribution till konsumenter genom apotek samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 |
|---|---|
| Revenue | 165 |
| Staff expenses | — |
| EBITDA | −118 |
| Depreciation & amort. | −12 |
| EBIT | −130 |
| Net financials | −12 |
| Profit before tax | −142 |
| Tax | −0 |
| Net profit | −142 |
| Item | 2021 |
|---|---|
| Total assets | 3 180 |
| Equity | 608 |
| Long-term debt | 652 |
| Short-term debt | 1 921 |
| Total debt | 2 573 |
EBITDA margin
-71.5%
This company
15.8%
Market median
-553% vs market
20212021
Equity ratio
19.1%
This company
38.2%
Market median
-50% vs market
20212021
Return on equity
-23.4%
This company
18.4%
Market median
-227% vs market
20212021
Net profit margin
-86.1%
This company
8.1%
Market median
-1163% vs market
20212021
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212021
Debt / equity
4.23×
This company
0.62×
Market median
-582% vs market
20212021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JL Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AZ PHARMA AB | Company | 99.0% | 99.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AZ PHARMA AB
Österängen C apotek AB Board members of Österängen C apotek AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Lars Lindgren | Chief Auditor | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Abdo Zarzour | Chairman | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Hanna Alnader | Deputy Board Member | 0 companies |
| Rama Jarad | Deputy Board Member | 0 companies |
| Ranin Mways | Board of Directors | 0 companies |